Literature DB >> 12095826

Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection.

Darius M Moshfeghi1, Careen Y Lowder, Daniel B Roth, Peter K Kaiser.   

Abstract

PURPOSE: To report a case of retinal and choroidal vascular occlusion occurring as a complication after posterior sub-Tenon triamcinolone injection for treatment of uveitic cystoid macular edema.
DESIGN: Interventional case report.
METHODS: Retrospective study. A 32-year-old woman with uveitis and cystoid macular edema underwent a right posterior sub-Tenon injection of triamcinolone (40 mg/ml, 1 ml total) through a superotemporal approach after topical anesthesia. After the procedure, the patient experienced severe eye pain, orbital ecchymosis, and globe proptosis consistent with retrobulbar hemorrhage.
RESULTS: Dilated fundus examination of the right eye (OD) demonstrated multiple intraretinal hemorrhages with particulate white emboli occluding the retinal and choroidal vessels. Visual acuity was no light perception. Ocular massage and hypotensive therapy was initiated for an intraocular pressure of 50 mm Hg. Canthotomy and cantholysis were performed. A total of 39 months post-incident, her visual acuity improved to 20/100.
CONCLUSION: Posterior sub-Tenon triamcinolone injection can rarely result in retinal and choroidal occlusion. Immediate intervention may preserve limited visual acuity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095826     DOI: 10.1016/s0002-9394(02)01426-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

Review 1.  Pharmacological treatments for thyroid eye disease.

Authors:  Sara P Modjtahedi; Bobeck S Modjtahedi; Ahmad M Mansury; Dinesh Selva; Raymond S Douglas; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Orbital steroid injections.

Authors:  R A Goldberg
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

3.  Severe retinal atrophy due to retinal and choroidal vascular occlusion following triamcinolone injection into the nasal mucosa.

Authors:  Akira Hirata; Mizue Kubo; Satoshi Okinami
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

4.  Trans-Tenon's retrobulbar injection of triamcinolone acetonide for diffuse diabetic macular edema.

Authors:  Mitsumasa Wada; Nahoko Ogata; Keizo Minamino; Masataka Koriyama; Akiko Higuchi; Miyo Matsumura
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

5.  Sub-Tenon's Steroid Irrigation for Treatment of Intraorbital Capillary Hemangioma.

Authors:  P G Firat; S Doganay; S Bilak; A Alkan
Journal:  Interv Neuroradiol       Date:  2008-02-01       Impact factor: 1.610

6.  Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Authors:  Rogério A Costa; Rodrigo Jorge; Daniela Calucci; Luiz A S Melo; José A Cardillo; Ingrid U Scott
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-28       Impact factor: 3.117

7.  Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.

Authors:  Tomoyo Koga; Yuki Mawatari; Junko Inumaru; Mikiko Fukushima; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-15       Impact factor: 3.117

8.  Changes in the morphology of the hyperemic blebs in eyes undergone trabeculectomy with mitomycin C after injection of triamcinolone acetonide during one-year follow-up.

Authors:  Zakieh Vahedian; Ghasem Fakhraie; Marzye Faraji; Seyed Mehdi Tabatabaei
Journal:  Int Ophthalmol       Date:  2021-06-25       Impact factor: 2.031

9.  Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis.

Authors:  A A Okada; T Wakabayashi; Y Morimura; S Kawahara; E Kojima; Y Asano; T Hida
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

Review 10.  [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors:  J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.